vs
Side-by-side financial comparison of Inogen Inc (INGN) and VICOR CORP (VICR). Click either name above to swap in a different company.
VICOR CORP is the larger business by last-quarter revenue ($113.0M vs $68.6M, roughly 1.6× Inogen Inc). On growth, VICOR CORP posted the faster year-over-year revenue change (20.2% vs 3.4%). Over the past eight quarters, VICOR CORP's revenue compounded faster (14.7% CAGR vs 4.2%).
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
Vicor Corporation is a manufacturer of power modules headquartered in Andover, Massachusetts.
INGN vs VICR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $68.6M | $113.0M |
| Net Profit | — | $20.7M |
| Gross Margin | 51.4% | — |
| Operating Margin | -13.6% | 59.7% |
| Net Margin | — | 18.3% |
| Revenue YoY | 3.4% | 20.2% |
| Net Profit YoY | — | 713.9% |
| EPS (diluted) | $-0.26 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $113.0M | ||
| Q4 25 | $68.6M | $107.3M | ||
| Q3 25 | $79.1M | $110.4M | ||
| Q2 25 | $79.2M | $96.0M | ||
| Q1 25 | $68.5M | $94.0M | ||
| Q4 24 | $66.3M | $96.2M | ||
| Q3 24 | $74.9M | $93.2M | ||
| Q2 24 | $74.4M | $85.9M |
| Q1 26 | — | $20.7M | ||
| Q4 25 | — | $46.5M | ||
| Q3 25 | $-5.3M | $28.3M | ||
| Q2 25 | $-4.2M | $41.2M | ||
| Q1 25 | $-6.2M | $2.5M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | $-6.0M | $11.6M | ||
| Q2 24 | $-5.6M | $-1.2M |
| Q1 26 | — | — | ||
| Q4 25 | 51.4% | 55.4% | ||
| Q3 25 | 52.2% | 57.5% | ||
| Q2 25 | 52.2% | 95.9% | ||
| Q1 25 | 53.1% | 47.2% | ||
| Q4 24 | 54.7% | 52.4% | ||
| Q3 24 | 55.2% | 49.1% | ||
| Q2 24 | 57.4% | 49.8% |
| Q1 26 | — | 59.7% | ||
| Q4 25 | -13.6% | 14.6% | ||
| Q3 25 | -9.0% | 18.9% | ||
| Q2 25 | -7.7% | 47.3% | ||
| Q1 25 | -11.2% | -0.2% | ||
| Q4 24 | -17.2% | 9.6% | ||
| Q3 24 | -10.4% | 5.8% | ||
| Q2 24 | -9.5% | 0.2% |
| Q1 26 | — | 18.3% | ||
| Q4 25 | — | 43.4% | ||
| Q3 25 | -6.7% | 25.6% | ||
| Q2 25 | -5.2% | 42.9% | ||
| Q1 25 | -9.0% | 2.7% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | -8.0% | 12.4% | ||
| Q2 24 | -7.5% | -1.4% |
| Q1 26 | — | $0.44 | ||
| Q4 25 | $-0.26 | $1.01 | ||
| Q3 25 | $-0.20 | $0.63 | ||
| Q2 25 | $-0.15 | $0.91 | ||
| Q1 25 | $-0.25 | $0.06 | ||
| Q4 24 | $-0.41 | $0.24 | ||
| Q3 24 | $-0.25 | $0.26 | ||
| Q2 24 | $-0.24 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.7M | $404.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $192.2M | $754.1M |
| Total Assets | $298.6M | $804.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $404.2M | ||
| Q4 25 | $103.7M | $402.8M | ||
| Q3 25 | $106.5M | $362.4M | ||
| Q2 25 | $103.7M | $338.5M | ||
| Q1 25 | $118.9M | $296.1M | ||
| Q4 24 | $113.8M | $277.3M | ||
| Q3 24 | $105.7M | $267.6M | ||
| Q2 24 | $97.9M | $251.9M |
| Q1 26 | — | $754.1M | ||
| Q4 25 | $192.2M | $711.6M | ||
| Q3 25 | $197.2M | $630.1M | ||
| Q2 25 | $199.5M | $608.6M | ||
| Q1 25 | $198.0M | $580.3M | ||
| Q4 24 | $173.9M | $570.1M | ||
| Q3 24 | $185.4M | $554.6M | ||
| Q2 24 | $187.6M | $537.2M |
| Q1 26 | — | $804.9M | ||
| Q4 25 | $298.6M | $785.8M | ||
| Q3 25 | $307.0M | $710.2M | ||
| Q2 25 | $312.0M | $693.5M | ||
| Q1 25 | $308.4M | $665.0M | ||
| Q4 24 | $296.2M | $641.1M | ||
| Q3 24 | $306.2M | $632.8M | ||
| Q2 24 | $308.9M | $613.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-943.0K | — |
| Free Cash FlowOCF − Capex | $-1.9M | — |
| FCF MarginFCF / Revenue | -2.8% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-13.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-943.0K | $15.7M | ||
| Q3 25 | $2.2M | $38.5M | ||
| Q2 25 | $4.3M | $65.2M | ||
| Q1 25 | $-16.8M | $20.1M | ||
| Q4 24 | $-3.0M | $10.1M | ||
| Q3 24 | $7.0M | $22.6M | ||
| Q2 24 | $6.7M | $15.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.9M | $10.2M | ||
| Q3 25 | $1.6M | $34.5M | ||
| Q2 25 | $3.7M | $59.0M | ||
| Q1 25 | $-17.1M | $15.6M | ||
| Q4 24 | $-3.3M | $8.4M | ||
| Q3 24 | $5.3M | $14.1M | ||
| Q2 24 | $6.6M | $9.4M |
| Q1 26 | — | — | ||
| Q4 25 | -2.8% | 9.5% | ||
| Q3 25 | 2.0% | 31.2% | ||
| Q2 25 | 4.6% | 61.5% | ||
| Q1 25 | -24.9% | 16.6% | ||
| Q4 24 | -5.0% | 8.7% | ||
| Q3 24 | 7.1% | 15.2% | ||
| Q2 24 | 8.9% | 11.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 5.2% | ||
| Q3 25 | 0.7% | 3.6% | ||
| Q2 25 | 0.9% | 6.5% | ||
| Q1 25 | 0.4% | 4.8% | ||
| Q4 24 | 0.5% | 1.8% | ||
| Q3 24 | 2.2% | 9.1% | ||
| Q2 24 | 0.1% | 7.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 7.93× | ||
| Q4 24 | — | 0.99× | ||
| Q3 24 | — | 1.95× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
VICR
| Product revenue | $98.0M | 87% |
| Royalty revenue | $15.0M | 13% |